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INTRODUCTION
The agglutination of sensitized sheep cells by a factor in the serum of
individuals with rheumatoid arthritis has been the subject of continued
investigation since its recognition by Waaler.' This reaction, with its modi-
fications, furnishes the useful diagnostic tests for the illness.1 2, 4, 9,
The hemagglutination reaction has also been used in the study of the
pathogenesis of rheumatoid arthritis. In this connection, efforts were made
to absorb the factor from serum"' or to identify it with a serum protein
fraction by virtue of differential solubility5"0" or rate of migration.6'7
These procedures have not been of significant help in the chemical
identification of the rheumatoid factor.
Rheumatoid arthritis is characterized clinically by the prominence of
changes in the synovial tissue and sometimes by the accumulation of joint
fluid. Therefore, it was decided to investigate synovial fluid with the
thought in mind that the joint itself might be the site of formation of the
rheumatoid factor or at least a source of this material which is ultimately
found circulating in the blood stream. Since the presence of mucin repre-
sents a significant difference between synovial fluid and serum, attention
was also focused upon it. The viscosity, mucin clot, and mucin nitrogen to
glucosamine ratio determinations reported by Ropes and Bauer8 indicate
that the hyaluronic acid of synovial fluid is depolymerized, or incompletely
polymerized, in rheumatoid arthritis.
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Such alterations of hyaluronic acid in synovial fluid have not previously
been related to the agglutination of sensitized sheep cells by the rheumatoid
factor. This study reports the effects of in vitro enzymatic treatment of
serum and synovial fluid in an attempt to learn if a relationship between
the hemagglutination test and the mucin polysaccharide does exist.
MATERIALS
Specimens. Synovial fluid samples were obtained from the knee joints of patients at
the Arthritis Clinic of the Grace-New Haven Community Hospital or from patients
under the care of private physicians. Aspirations were performed, with aseptic pre-
cautions, when clinical evidence of joint effusion existed. The fluids were kept at
40 C. for 12 hours, then centrifuged. The fibrin clot, cells, and debris, if any, were
discarded and the supernatant fluid stored at -10° C.
Whenever possible, blood was collected from the individual at the time of the knee
tap. For the purpose of this study, however, serum and synovial fluid samples were
considered contemporary if collected within one week of each other.
Enzymes. Hyaluronidase and f8-glucuronidase were purchased from a commercial
source.* The bovine testicular hyaluronidase had a reported assay value of 150-250
Turbidity Reducing Units per milligram. The activity of the bovine liver 8-glucuroni-
dase was given as approximately 50,000-70,000 units per gram.
Buffers. A pH 6.0 acetate buffer, 0.15 M with respect to sodium chloride, was
prepared by diluting 6 ml. of 0.5 M acetic acid, 19.4 ml. of 0.5 sodium acetate and
8.77 gm. of sodium chloride to 1 liter with distilled water.
A pH 4.5 buffer was prepared from 11 ml. of 0.2 M acetic acid and 9 ml. of 0.2 M
sodium acetate.
METHODS
Hemagglutinzation Test
A recent modification of the hemagglutination test was used.' It employs the settled
pattern of sensitized sheep cells to indicate the endpoint of the reaction. Results are
expressed in units which are the reciprocal of the test material dilution at which the
last positive pattern occurred. Less than eight units is a negative test. Except for
the inclusion of synovial fluids and the use of enzymes for treatment, the hemaggluti-
nation method is that previously described. To insure comparable results the con-
temporary samples of serum and synovial fluid were always included in the same unit
of hemagglutination tests.
Enzyme Experiments
Bovine testicular hyaluronidase was dissolved in pH 6.0 buffer to give final concen-
tration of 0.25, 0.50, 1.0, 2.5, 5.0, and 10.0 mg. per 0.3 ml. of the buffer; 0.3 ml. of the
enzyme containing buffer was then added to an equal volume of serum or synovial
fluid. The mixture was incubated for one hour at 370 C. Enzyme-treated synovial
fluid or serum samples, along with untreated control samples, were assayed by the
* Worthington Biochemical Corporation, Freehold, New Jersey.
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hemagglutination test. The final titer and the settled red cell pattern at each dilution
were recorded.
A similar procedure was used with p-glucuronidase. This enzyme was dissolved,
however, in pH 4.5 buffer, and the pH was readjusted with 0.1 M sodium hydroxide to
approximately 6.5 after incubation and just before assay.
RESULTS
In Table 1 the hemagglutination test results of 19 contemporary serum
and synovial fluid samples from 16 patients are given. It is apparent, in the
series studied, that the incidence of a positive hemagglutination test in
serum is greater than in synovial fluid. In the three instances in which both
the serum and synovial fluid gave positive hemagglutination tests, the titer
of the synovial fluid was consistently higher by one or two dilutions. From
general use in this laboratory, the maximum limit of error for the test is
placed at one dilution.
After preliminary studies on ,8-glucuronidase-treated serum and synovial
fluid samples and similar samples treated with hyaluronidase, it was evident
that the only treatment which significantly altered the hemagglutination test
was the hyaluronidase treatment of certain synovial fluids. Therefore, the
principal effort was concentrated on the effect of hyaluronidase on all
available synovial fluids.
Preliminary experiments indicated that 1 mg. of hyaluronidase (150-250
T.R.U.) per 0.3 ml. of synovial fluid was a satisfactory enzyme concentra-
tion. Higher concentrations failed to elevate the titer further while lower
concentrations occasionally failed to give optimal results. Control experi-
ments showed that in the absence of the enzyme neither the pH 6.0 buffer
nor the period of incubation altered the hemagglutination test. Further-
nore, the buffered enzyme alone did not agglutinate sensitized sheep cells.
Table 1 also gives the synovial fluid hemagglutination test results, before
and after hyaluronidase treatment, of the 16 patients with contemporary
serums. In those instances (F.G., C.G.) where a positive titer was found in
the synovial fluid before enzyme treatment, the action of hyaluronidase
resulted either in no change or in a reduction in titer. In cases in which the
serum hemagglutination test was positive but the synovial fluid test was
negative, enzyme treatment of the synovial fluid resulted in a positive
hemagglutination test (A.K., A.Cr., C.Fr., L.A.). The titer of the enzyme-
treated synovial fluid in such cases was higher, with one exception (A.Cr.),
than the titer of the corresponding serum. In addition, five hyaluronidase-
treated synovial fluids had significantly positive hemagglutination tests,
while the contemporary serums were negative (M.S., I.T., A.C., A.P.,
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TABLE 1. COMPARISON OF THE HEMAGGLUTINATION TEST RESULTS OF
CONTEMPORARY SERUMS, SYNOVIAL FLUIDS, AND HYALURONIDASE-
TREATED SYNOVIAL FLUIDS
Hemagglutination titer*
Diagnosis Patient Serum
Group I
Rheumatoid arthritis
Juvenile rheumatoid
arthritis
F.G. I
M.S.
A.K.
C.G.
I.T.
A.Cr.
C.Fr.
A.C.
V.W.
C.F.
11-21-55 256
1-16-56 512
11- 5-56 128
<8
128
512
<8
256
128
<8
8-30-56 <8
9-15-56 <8
<8
Group II
Possible rheumatoid
arthritis
Rheumatoid arthritis or
lupus erythematosus
Gonococcal arthritis
history-possible
rheumatoid arthritis
Gouty arthritis-
possible rheumatoid
arthritis
Group III
Traumatic arthritis
A.P.
H.L.
L.A.
R.V.
<8
<8
64
<8
J.T.
S.S.
<8 64
<8 8
<8 512
<8 <8
<8 <8 <8
<8 <8 <8
Synovial fluid
Synovial after hyaluroni-
fluid dase treatment
512
1024
<8
<8
<8
2048
<8
<8
<8
<8
<8
<8
<8
512
512
512
8
256
256
64
64
256
8
<8
<8
<8
* Expressed in units as reciprocals of serum or synovial fluid dilutions. Less than
8 units is a negative test.
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II.L.). Three of these were from cases of rheumatoid arthritis and two
from cases diagnosed as possible rheumatoid arthritis.
The means by which hyaluronidase produces a positive hemagglutination
test was partially elucidated by examination of the actual settled sheep cell
patterns. Many synovial fluids had sheep cell patterns which were atypical
and could not be assigned a titer. These patterns were neither negative nor
typically positive, but represented a third type of pattern which was distinct
and easily recognizable. Upon addition of hyaluronidase, such fluids pre-
sented typically positive patterns and could be assigned a titer. This titer
corresponded to the last dilution in which an atypical pattern appeared in
the synovial fluid alone.
A few synovial fluid samples (M.S., A.C., H.L.) gave a clear-cut
negative pattern in the hemagglutination test, but after treatment with
hyaluronidase the hemagglutination test became typically positive at a titer
of eight units.
In addition to the sixteen patients from whom both synovial fluid and
serum were available, synovial fluid from fourteen other patients was
studied. The hemagglutination titers of 43 synovial fluids, before and after
hyaluronidase treatment, are given in Table 2.
To evaluate the specificity of the effect of hyaluronidase it was necessary
to study its effect on synovial fluids of nonrheumatoid origin. Group 3 of
Table 2 contains nine such patients. The post-mortem synovial fluid served
as a normal control. The occurrence of a positive hemagglutination test in
one case of traumatic arthritis indicates either that the effect of hyaluroni-
dase is not entirely specific for rheumatoid arthritis or that in this case the
diagnosis may change with time to that of rheumatoid arthritis.
DISCUSSION
The low incidence of a positive hemagglutination test in untreated
synovial fluid and the difficulty and trauma associated with obtaining
synovial fluid would seem to make it an undesirable material for the appli-
cation of the routine diagnostic hemagglutination test. However, when
synovial fluid is treated with hyaluronidase, prior to assay, the incidence of
a positive hemagglutination test is increased, and under these circum-
stances synovial fluid provides at least as much information as the usual
serum hemagglutination test. It may provide additional diagnostic informa-
tion, but this cannot be established until more data on the specificity of the
effect of hyaluronidase on the hemagglutination test are available.
Although it is unlikely that hyaluronidase acts in vitro to produce the
rheumatoid factor, it either makes it more available for reaction with sensi-
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TA;BLE 2. COMPARISON OF THE HEMAGGLUTINATION TEST RESULTS OF
SYNOVIAL FLUIDS AND HYALURONIDASE TREATED SYNOVIAL FLUIDS
Diagnosis
Group I
Rheumatoid arthritis
Patient
F.G. 10-31-55
11-21-55
12- 5-55
1-16-56
3- 5-56
5-21-56
11- 5-56
M.S. 2-27-56
2-29-56
3- 7-56
2-26-56
A.K.
C.G.
I.T.
A.Cr.
C.Fr. 4-16-56
5-28-56
A.C. 5-29-56
6- 6-56
A.J.
H.H.
V.W.
Juvenile rheumatoid
arthritis
F.H.
J.w.
C.F.
8-30-56
9-15-56
9- 7-56
9-12-56
Group II
Probable rheumatoid
arthritis
Possible rheumatoid
arthritis
Rheumatoid arthritis or
lupus erythematosus
Hemagglutination titer
Synovial fluid
Synovial after hyaluroni-
fluid dase treatment
1024
512
1024
1024
1024
1024
<8
<8
<8
<8
<8
<8
2048
<8
<8
<8
<8
<8
<8
<8
<8
<8
<8
<8
<8
<8
<8
512
512
1024
512
512
512
512
8
<8
<8
<8
256
256
64
64
256
512
8
<~8-
128
<8
<8
<8
16
<8
<8
8
D.G. <8
A.P.
N.E.
H.L.
L.A.
<8
64
16
8
512
<8
<8
<8
<8
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Hemagglutination titer
Synovial
fluid Patient
Synovial fluid
after hyaluroni-
dase treatment
Gonococcal arthritis
history-possible
rheumatoid arthritis
Gouty arthritis
possible rheumatoid
arthritis
R.V. <8 <8
J.T. <8 <8
Group III
Gouty arthritis
Degenative joint
disease
Scleroderma
Traumatic arthritis
Post-mortem*
L.C.
R.P.
E.M.
G.P.
S.S.
C.K.
G.R.
N.O.
J.c.
<8 <8
<8 <8
<8 <8
<8 <8
<8 <8
<8 <8
<8 <8
<8 16
<8 <8
* No history or clinical signs of joint disease.
tized sheep cells or it may depolymerize an inhibitory mucopolysaccharide.
It is unclear exactly how this is accomplished, but it would appear that the
effect must be ascribed to some chemical change induced by hyaluronidase.
Hyaluronidase reduces the viscosity of synovial fluid by depolymerizing the
polysaccharide, hyaluronic acid. The physical change in viscosity itself does
not seem to be the responsible alteration, since preliminary experiments
indicate that hyaluronidase can convert atypical hemagglutination patterns
to typically positive ones even when a high viscosity is artificially main-
tained with glycerol or methocel.
SUMMARY
1. A comparison of the hemagglutination test results is made with serum
and synovial fluid samples obtained from the same individual.
2. In cases in which the serum hemagglutination test was positive but
the synovial fluid did not produce the usual endpoint, hyaluronidase treat-
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ment of the synovial fluid resulted in a positive pattern of settled sheep
cells. In addition, after hyaluronidase treatment, some synovial fluids gave
positive hemagglutination tests of low titer, while the corresponding serum
test did not react.
3. The effect of hyaluronidase on this hemagglutination test of synovial
fluid suggests a correlation between the rheumatoid factor, or an inhibiting
substance, and the mucin polysaccharide.
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